Acta Neuropathologica

Article	Citations
Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD	147
A novel subtype of sporadic Creutzfeldt–Jakob disease with PRNP codon 129MM genotype and PrP plaques	136
Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy	129
The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers	122
Capillary basement membrane reduplication in myositis patients with mild clinical features of systemic sclerosis supports the concept of ‘scleromyositis’	115
Regulated cell death and its role in Alzheimer’s disease and amyotrophic lateral sclerosis	114
Macrophages and endothelial cells in the neurovascular unit	103
Co-registration of MALDI-MSI and histology demonstrates gangliosides co-localize with amyloid beta plaques in Alzheimer’s disease	99
Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer’s Coordinating Center database	91
Wolframin is a novel regulator of tau pathology and neurodegeneration	89
Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry	84
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma	83
BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repair	74
SCN1A overexpression, associated with a genomic region marked by a risk variant for a common epilepsy, raises seizure susceptibility	73
Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum	71
A familial missense variant in the Alzheimer’s disease gene SORL1 impairs its maturation and endosomal sorting	70
RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation	68
RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS	67
Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype	62
Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics	60
Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases	59
Progranulin deficiency results in sex-dependent alterations in microglia in response to demyelination	59
TREM2 gene expression associations with Alzheimer’s disease neuropathology are region-specific: implications for cortical versus subcortical microglia	56
TDP-43 pathology in the retina of patients with frontotemporal lobar degeneration	53
Detection of blood–brain barrier disruption in brains of patients with COVID-19, but no evidence of brain penetration by SARS-CoV-2	52

The Alzheimer’s disease GWAS risk alleles in the ABCA7 promoter and 5’ region reduce ABCA7 expression	52
Cell-specific MAPT gene expression is preserved in neuronal and glial tau cytopathologies in progressive supranuclear palsy	51
Multi-level profiling unravels mitochondrial dysfunction in myotonic dystrophy type 2	51
TBK1 haploinsufficiency in ALS and FTD compromises membrane trafficking	51
Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges	50
From metabolomics to proteomics: understanding the role of dopa decarboxylase in Parkinson’s disease. Scientific commentary on: “Comprehensive proteomics of CSF, plasma, and urine identify DDC and oth	50
Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma	50
Tau seeding in chronic traumatic encephalopathy parallels disease severity	49
Expanding the spectrum of amyloid-β plaque pathology: the Down syndrome associated ‘bird-nest plaque’	45
Neuropathological associations of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) differ between the oldest-old and younger-old	45
Jorge Cervós-Navarro 1930–2021	45
Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy	45
Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis	44
Landscape of brain myeloid cell transcriptome along the spatiotemporal progression of Alzheimer’s disease reveals distinct sequential responses to Aβ and tau	43
Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson’s disease-related fibril polymorphism	42
Variants in DTNA cause a mild, dominantly inherited muscular dystrophy	41
Clinicopathological and molecular characterization of three cases classified by DNA-methylation profiling as “Glioneuronal Tumors, NOS, Subtype A”	39
Clinical applicability of miR517a detection in liquid biopsies of ETMR patients	38
DTYMK is essential for genome integrity and neuronal survival	37
PolyGA targets the ER stress-adaptive response by impairing GRP75 function at the MAM in C9ORF72-ALS/FTD	37
Correction to: α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy	37
Correction to: MET receptor serves as a promising target in melanoma brain metastases	37
Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI	37
White matter microglia heterogeneity in the CNS	35
Novel lissencephaly-associated NDEL1 variant reveals distinct roles of NDE1 and NDEL1 in nucleokinesis and human cortical malformations	35
Xenografted human iPSC-derived neurons with the familial Alzheimer’s disease APPV717I mutation reveal dysregulated transcriptome signatures linked to synaptic function and implicate LINGO2 as a diseas	35
Rapid-CNS2: rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof-of-concept study	35
CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease	35
The variance in phosphorylated, insoluble ⍺-synuclein in humans, rats, and mice is not mainly driven by biological sex	34
A CHCHD6–APP axis connects amyloid and mitochondrial pathology in Alzheimer’s disease	34
Co-expression of APP/PS1 disrupts the distribution of brain lesions in a synucleinopathy transgenic mouse model (M83)	34
Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 2204	34
Physiological aging and inflammation-induced cellular senescence may contribute to oligodendroglial dysfunction in MS	33
Correction to: Large‑scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease	33
Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease	33
Myofiber-type-dependent ‘boulder’ or ‘multitudinous pebble’ formations across distinct amylopectinoses	33
From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions	32
Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease	32
Chronic traumatic encephalopathy in a female ex-professional Australian rules footballer	32
Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma	32
Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations	32
Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function	32
Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis	32
DGCR8 and the six hit, three-step model of schwannomatosis	32
EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma	31
Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change	31
Tau seeds occur before earliest Alzheimer’s changes and are prevalent across neurodegenerative diseases	31
Impaired GABAergic regulation and developmental immaturity in interneurons derived from the medial ganglionic eminence in the tuberous sclerosis complex	31
HnRNP K mislocalisation is a novel protein pathology of frontotemporal lobar degeneration and ageing and leads to cryptic splicing	31
Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab	30

Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology	30
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1	30
An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD	29
The prevalence and topography of spinal cord demyelination in multiple sclerosis: a retrospective study	29
Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration	29
Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE	29
Fatal encephalitis caused by Newcastle disease virus in a child	28
Disruption of the blood–brain barrier is correlated with spike endocytosis by ACE2 + endothelia in the CNS microvasculature in fatal COVID-19. Scientific commentary on "Detection of blood–brain barrie	28
Alteration of LARGE1 abundance in patients and a mouse model of 5q-associated spinal muscular atrophy	28
Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas	28
Decreased dystrophin expression and elevated dystrophin-targeting miRNAs in anti-HMGCR immune-mediated necrotizing myopathy	28
Concussion leads to widespread axonal sodium channel loss and disruption of the node of Ranvier	27
Urinary tract infections trigger synucleinopathy via the innate immune response	27
Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer’s disease pathology progression	27
p-tau Ser356 is associated with Alzheimer’s disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003	27
Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts	27
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development	27
Characterisation of premature cell senescence in Alzheimer’s disease using single nuclear transcriptomics	27
Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas	26
A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer’s disease	26
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease	26
Neuroinflammatory disease signatures in SPG11-related hereditary spastic paraplegia patients	26
Loss of the heterogeneous expression of flippase ATP11B leads to cerebral small vessel disease in a normotensive rat model	26
Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1	26
Hemorrhagic lesion with detection of infected endothelial cells in human bornavirus encephalitis	26
Retinal pathological features and proteome signatures of Alzheimer’s disease	25
Phenotypic diversity of genetic Creutzfeldt–Jakob disease: a histo-molecular-based classification	25
Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS	25
DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma	24
DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival	24
Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer’s disease and related tauopathies	24
More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy	24
“De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade	24
Nanopore sequencing from formalin-fixed paraffin-embedded specimens for copy-number profiling and methylation-based CNS tumor classification	24
Oncostatin M triggers brain inflammation by compromising blood–brain barrier integrity	24
CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas	24
Transmission experiments verify sporadic V2 prion in a patient with E200K mutation	24
DNA methylation-based classification of malformations of cortical development in the human brain	23
Ferroptosis inhibitor improves outcome after early and delayed treatment in mild spinal cord injury	23
Scientific commentary on: “Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer’s disease and primary tauopathies”	23
Vagus nerve inflammation contributes to dysautonomia in COVID-19	23
DNA methylation analysis of archival lymphoreticular tissues in Creutzfeldt–Jakob disease	23
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions	22
Methylation class oligosarcoma may encompass IDH-wildtype gliomas	22
Subgroup and subtype-specific outcomes in adult medulloblastoma	22
Individual myasthenia gravis autoantibody clones can efficiently mediate multiple mechanisms of pathology	22
Neuropathology of central nervous system involvement in TTR amyloidosis	22
The choroidal nervous system: a link between mineralocorticoid receptor and pachychoroid	22
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13	21
Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is independently associated with dementia and strongly associated with arteriolosclerosis in the oldest-old	21
Head-to-head comparison of [18F]-Flortaucipir, [18F]-MK-6240 and [18F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases	21
Professor Charles Duyckaerts (1951–2022)	21
Methylation class oligosarcoma, IDH-mutant could exhibit astrocytoma-like molecular features	21
The perils of contact sport: pathologies of diffuse brain swelling and chronic traumatic encephalopathy neuropathologic change in a 23-year-old rugby union player	21
Transcriptomic analysis of frontotemporal lobar degeneration with TDP-43 pathology reveals cellular alterations across multiple brain regions	21
Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: “it’s a numbers game”—implications for WNT medulloblastoma dose-reduction clinical trials	21
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children’s Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials	21
Archival wild-type poliovirus 1 infected central nervous system tissues of the pre-vaccination era in Switzerland reveal a distinct virus genotype	21
Immunohistochemistry as a tool to identify ELP1-associated medulloblastoma	21
Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer’s disease	20
Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice	20
Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features	20
Signature laminar distributions of pathology in frontotemporal lobar degeneration	20
Selective vulnerability of tripartite synapses in amyotrophic lateral sclerosis	20
TMEM106B coding variant is protective and deletion detrimental in a mouse model of tauopathy	20
Persistent virus-specific and clonally expanded antibody-secreting cells respond to induced self-antigen in the CNS	20
The neuropathology of intimate partner violence	20
Cross-regional homeostatic and reactive glial signatures in multiple sclerosis	20
Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease	20
Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival	20
Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion	19
Loss of function variants in DNAJB4 cause a myopathy with early respiratory failure	19
Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers	19
Association of small vessel disease with tau pathology	19
Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome	18
Microglia activation in periplaque white matter in multiple sclerosis depends on age and lesion type, but does not correlate with oligodendroglial loss	18
Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer’s disease	18
Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer’s disease	18
Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformations	18
Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus	18

Seeding activity of human superoxide dismutase 1 aggregates in familial and sporadic amyotrophic lateral sclerosis postmortem neural tissues by real-time quaking-induced conversion	18
Annexin A11 aggregation in FTLD–TDP type C and related neurodegenerative disease proteinopathies	17
α-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders	17
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma	17
New evidence suggests SARS-CoV-2 neuroinvasion along the nervus terminalis rather than the olfactory pathway	17
Characterization of hippocampal sclerosis of aging and its association with other neuropathologic changes and cognitive deficits in the oldest-old	17
Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer’s disease	17
Multiple system atrophy prions transmit neurological disease to mice expressing wild-type human α-synuclein	17
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification	17
Neuronal tau pathology worsens late-phase white matter degeneration after traumatic brain injury in transgenic mice	17
Expanding the phenotype and genotype spectra of PLIN4-associated myopathy with rimmed ubiquitin-positive autophagic vacuolation	17
Cryo-EM structures of amyloid-β filaments with the Arctic mutation (E22G) from human and mouse brains	17
Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis	17
Consequences of variability in α-synuclein fibril structure on strain biology	17
Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease	17
Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas	17
Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics	17
Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis	17
Brain DNA methylomic analysis of frontotemporal lobar degeneration reveals OTUD4 in shared dysregulated signatures across pathological subtypes	16
Novel actionable ROS1::GIT2 fusion in non-Langerhans cell histiocytosis with central nervous system involvement	16
Similar brain proteomic signatures in Alzheimer’s disease and epilepsy	16
Anaplastic histology and distinct molecular features in a small series of spinal cord ependymomas	16
Complement-associated loss of CA2 inhibitory synapses in the demyelinated hippocampus impairs memory	16
Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo	16
Transmission of cervid prions to humanized mice demonstrates the zoonotic potential of CWD	16
Flow blockage disrupts cilia-driven fluid transport in the epileptic brain	16
Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours	16
Seizure-mediated iron accumulation and dysregulated iron metabolism after status epilepticus and in temporal lobe epilepsy	15
LRRK2 is reduced in Parkinson’s disease gut	15
Inflammation and the pathological progression of Alzheimer’s disease are associated with low circulating choline levels	15
New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis	15
Genome-wide association study and functional validation implicates JADE1 in tauopathy	15
Generation of patient-derived models from a metastatic pediatric diffuse leptomeningeal glioneuronal tumor with KIAA1549::BRAF fusion	15
Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification	15
MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons	14
Heterogeneity of white matter astrocytes in the human brain	14
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors	14
Correction to: Disruption of MAM integrity in mutant FUS oligodendroglial progenitors from hiPSCs	14
Cryo-EM structures of prion protein filaments from Gerstmann–Sträussler–Scheinker disease	14
Viral entry and translation in brain endothelia provoke influenza-associated encephalopathy	14
Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression	14
A recurrent homozygous ACTN2 variant associated with core myopathy	14
A point mutation in GPI-attachment signal peptide accelerates the development of prion disease	14
Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts	13
Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice	13
Perivascular space dilation is associated with vascular amyloid-β accumulation in the overlying cortex	13
AMFR dysfunction causes autosomal recessive spastic paraplegia in human that is amenable to statin treatment in a preclinical model	13
Risk of chronic traumatic encephalopathy in rugby union is associated with length of playing career	13
Mutant LRRK2 exacerbates immune response and neurodegeneration in a chronic model of experimental colitis	13
EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma	13
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease	13
Correction to: Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS	13
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden	13
Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia	13
A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies	12
Dysregulation of astrocytic Ca2+ signaling and gliotransmitter release in mouse models of α-synucleinopathies	12
Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer’s disease	12
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum	12
Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy	12
Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains	12
Single-cell DNA sequencing reveals order of mutational acquisition in TRAF7/AKT1 and TRAF7/KLF4 mutant meningiomas	11
Neuronal spreading and plaque induction of intracellular Aβ and its disruption of Aβ homeostasis	11
Tuberous sclerosis complex is associated with a novel human tauopathy	11
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease	11
Complement activation contributes to GAD antibody-associated encephalitis	11
Associations of psychiatric disease and ageing with FKBP5 expression converge on superficial layer neurons of the neocortex	11
Genetic and epigenetic profiling identifies two distinct classes of spinal meningiomas	11
Somatic LINE-1 promoter acquisition drives oncogenic FOXR2 activation in pediatric brain tumor	11
Soluble oligomers or insoluble fibrils? Scientific commentary on “Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau”	11
Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer’s disease	11
Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease	11
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors	11
Early white matter pathology in the fornix of the limbic system in Huntington disease	11
Variant allelic frequency of driver mutations predicts success of genomic DNA methylation classification in central nervous system tumors	11